Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
about
Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and raceDifferences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella reviewGender-related differences in pharmacokinetics and their clinical significance.Immunosuppressive interactions among calcium channel antagonists and selected corticosteroids and macrolides using human whole blood lymphocytes.Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.Altered methylprednisolone pharmacodynamics in healthy subjects with histamine N-methyltransferase C314T genetic polymorphism.Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in ratsPharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat.Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.Gender differences in drug effects: implications for anesthesiologists.Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.Expanding clinical applications of population pharmacodynamic modelling.Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.Gender-based personalized pharmacotherapy: a systematic review.Pharmacokinetic-pharmacodynamic modelling: history and perspectives.The role of stress mediators in modulation of cytokine production by ethanol.Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures? A meta-analysis.Differences between serum polar lipid profiles of male and female rheumatoid arthritis patients in response to glucocorticoid treatment.Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.Neuroendocrine-immune interactions and responses to exercise.Hormonal regulation of hepatic drug biotransformation and transport systems.Gender specificity of tolterodine on micturition and the diurnal variation of urine production of the conscious rat.Sex differences in pharmacokinetics and pharmacodynamics.Gender differences in pharmacokinetics.Steroids in late ARDS?Time-variant increase in methylprednisolone clearance in patients with acute respiratory distress syndrome: a population pharmacokinetic study.Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.Population pharmacodynamic modeling without plasma concentrations of rocuronium in children.Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics.Lack of a fluoxetine effect on prednisolone disposition and cortisol suppression.Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.Pharmacokinetics and pharmacodynamic response of methylprednisolone in premenopausal renal transplant recipients.REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy.Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults.Modelling propofol pharmacodynamics using BIS-guided anaesthesia.Characterization of four basic models of indirect pharmacodynamic responses.Our Environment Shapes Us: The Importance of Environment and Sex Differences in Regulation of Autoantibody Production.
P2860
Q28363529-27292CD8-13FE-485F-A3C6-E1261B0C7F0AQ28474985-AC5604EC-332B-4D36-845E-4D942EC9F245Q33785861-46962460-7D24-456B-8C31-8FBF4D4AD653Q34260591-A41333B2-18F7-4C7A-B7AF-E866C3458D26Q34278794-1CE39826-C869-4E42-A39D-D9F2D4AD22B0Q34335692-D4A17651-179A-45C2-9EB6-24D07FF6B621Q34392713-D1194256-D883-4C72-94C6-6EBE453B7093Q34392874-742CAEBA-6952-49D5-92C7-369ABACA9DF7Q34392896-50EB392E-E16A-4D04-AA1F-B939D69DF7FDQ35089206-D45A624F-8B84-4B0D-A5C5-D2E0DA22AD97Q35802149-A67C6F77-2959-4CB5-A9C4-F7EC10E53E28Q35803310-1C372AB0-35EF-48FD-8693-15B0C19C6A83Q35803868-0EDEDE3C-D2E6-4B28-B167-A3043D374F32Q36335289-62ED9CAB-B74B-4F1D-8DF0-F45D8057748BQ36365141-CA76815E-0665-4525-8338-26378899D5EBQ37286866-27FA98E5-1570-4DA9-9BEF-B64BA3FE5262Q37402958-AA841C94-F036-4897-B679-6621A142E337Q37429572-738EBFE2-510B-4806-8923-46CF969DA16CQ37591508-B84A6491-AE80-4E7B-ACA6-2302CB026708Q37903837-FD8A0D55-A79C-4FFB-AAE7-FDF0038DE241Q38165145-B0E521D6-EACD-4379-A74F-EDF23878E8F7Q39551607-CF692FEE-978A-4AB2-918A-661FD228CD6AQ40398634-1E95E1AF-333C-4671-993E-4F1A02A3C6EDQ41138044-CDCDDBEF-7249-4A14-854D-C54B8A90FC2FQ42111189-394DB834-FEBE-46D9-BE27-34C3E8475072Q42647526-651278E7-27DE-46E5-8DC2-D05D38901D48Q43673452-D059CD7C-0586-41D1-B434-9D96C14D4E10Q43864978-63E7565C-72B1-4648-B859-5EE647BC4691Q44613020-D71D4362-B546-41DA-BA69-A44668E2B2ACQ44852169-8983867C-4D7D-4FD6-A7A8-CAE23029B2BCQ44904396-5C1FAF6A-FDBD-4DEA-B554-5D4171C39DA3Q45022891-D2759A4B-AA6B-4321-8B27-3ED4717AF1D0Q45884215-50740F93-7837-433F-9619-57C467EA8E3CQ46954390-3136518D-CB4C-4B11-9955-EB81EBC646E8Q47976195-E0D4463D-F44E-4378-A109-8A27FAEA2F3AQ52288614-BB7CB5D1-2BA3-4CDB-95AF-3272D4BADDAFQ52691361-F5CCF4F2-CC11-4BCF-B2E7-6454BEA98D92
P2860
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@ast
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@en
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@nl
type
label
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@ast
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@en
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@nl
prefLabel
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@ast
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@en
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@nl
P2093
P2860
P356
P1476
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
@en
P2093
E A Ludwig
E Middleton
P2860
P304
P356
10.1038/CLPT.1993.167
P407
P577
1993-10-01T00:00:00Z